Xeris Biopharma Holdings, Inc.
XERS· Nasdaq
Xeris Biopharma Holdings, Inc.
- Last sale
- Oct 1, 2026 · -2.99%
- Market cap
- $1.69B
- 182.32M shares
- Filings
- 333
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $291,845,000 | reported | |
| FY 2024 | 2024-12-31 | $203,070,000 | reported | |
| FY 2023 | 2023-12-31 | $163,914,000 | reported | |
| FY 2022 | 2022-12-31 | $110,248,000 | reported | |
| FY 2021 | 2021-12-31 | $49,590,000 revised | reported | |
| FY 2020 | 2020-12-31 | $20,155,000 | reported |
Xeris Biopharma Holdings, Inc. · CIK 1867096 · Engraved from SEC EDGAR
